for the branched chain. Peptidyl-resin was washed between coupling cycles with DMF for 3 minutes by alternating batch or flow washes. Peptides were cleaved from the resin using 94% TFA, 1% triisopropylsilane (TIS), 2.5% ethanedithiol, and 2.5% H2O (cleavage cocktail) (Supplementary Fig. 3 ). Crude peptide products were precipitated and washed with cold Et2O, dissolved in solvent A with a minimal amount of solvent B and then purified by RP-HPLC and characterized by ESI-MS ( Supplementary Fig. 4 ).
Synthesis of peptide used in the semi-synthesis of construct 1
Linear chain Cys 184 -Pro +4 (residue numbers refer to GyrA intein) was assembled using the synthetic methods as described above. Fmoc-Thr-OH and Boc-Cys(Trt)-OH were used to selectively elongate the branched chain at the Thr side chain. Undesired Thr side chain acylation was cleaved with ethanolamine in 5% water/DMF (2 x 30 min). Fmoc-Tyr(Trt)-OH was coupled to the b-hydroxyl of the Thr side chain using the symmetric anhydride method (10 eq. aa) with DICP and (0.1 eq.), DMAP (dimethylaminopyridine) (1 x 3 h) followed by a second coupling (1 x o/n) using Fmoc-Tyr(Trt)-OH (4 eq.) activated with MSNT (1-(2-mesi-tylenesulfonyl)-3-nitro-1H-1,2,4-triazole) (4 eq.) and MNI (Nmethylimidazole) (12 eq.). All subsequent residues were coupled using 5 eq. of amino acid and 5 eq. of DICP and HOBt (1 x 1 h) with 2% DBU in DMF (1 x 10 min) used to deprotect the Fmoc group. Following cleavage, the crude peptide was purified by RP-HPLC (C 18 column, gradient of 20-40% solvent B) and the molecular weight confirmed by ESI-MS (observed 3759.96 ±1.15, expected 3759.1 Da). The isolated yield after synthesis and purification was ~18%.
Synthesis of peptide used in the semi-synthesis of construct 2, 3 and 4
Linear chain Cys 184 -Pro +4 -His 6 was assembled using the synthetic methods as described above using HBTU and DIEA. Following cleavage, the crude peptide was purified by Fmoc-Tyr(Trt)-OH was coupled using HBTU and DIEA. The remaining residues were coupled using HBTU and DIEA as above with 20% piperidine in DMF (2 x 10 min) used to remove the Fmoc protecting groups. Following cleavage, the lyophilized crude peptide was added to 0.5 M methoxylamine in water and the solution agitated for 6 hours at 37
°C. The desired product was the major product (~95%) as determined by RP-HPLC. The peptide was purified by RP-HPLC (C 18 column, gradient of 20-40% solvent B) and the molecular weight confirmed by ESI-MS (observed 3744.48±0.9, expected 3744.32 Da).
The isolated yield after synthesis and purification was ~14%.
Synthesis of peptide 9
Linear chain Nvoc-Thr +1 -Pro +4 (residue numbers refer to GyrA extein residues) was assembled using the synthetic methods described above, except that Nvoc-Thr-OH was used in place of Fmoc-Thr-OH. Undesired Thr side chain acylation was cleaved with ethanolamine in 5% water/DMF (2 x 30 min). δ 174. 13, 157.28, 144.73, 141.57, 128.51, 127.92, 126.23, 121.01, 66.61, 60.47, 47.53, 30.46, 20.08, 19.04 . ESI-MS expected (M+H+) 341.4, observed 341.0.
Construction of Plasmids
The DNA encoding the Mxe GyrA intein (residues 1-184) was PCR amplified from the pTXB1 vector to incorporate an additional N-terminal His 6 -tag and the Factor Xa recognition site. This PCR product was re-cloned back into the NdeI and SapI restrictions sites of the pTXB1 vector, which contain a mutated Mxe GyrA intein and the chitinbinding domain. Note, mutation of Cys1 was also found to be required for efficient production of the recombinant intein a-thioester fragments required for the EPL reaction.
The C1S mutation was then introduced using Quick-Change mutagenesis kit (Stratagene) to generate the final fusion protein (His 6 -Xa-Ser1-(2-184)-GyrACBD) used to prepare branched constructs. To prepare the fusion protein (His 6 -Xa-AMRY-Ala1-(2-184)-GyrACBD) used in the linear construct 3, Quick-Change mutagenesis kit was used to introduce four N-extein residues (AMRY) and to mutate the Ser1 to Ala.
Protein Expression
E. coli BL21 (DE3) Upon reaching an OD 600 ~0.8, protein expression was induced with 0.5 mM IPTG (Isopropyl β-D-1-thiogalactopyranoside) at 37 °C for 3 h. The cells were centrifuged and the pellet suspended in five volumes of lysis buffer (50 mM Tris-HCl pH 7.9, 2 mM EDTA, 500 mM NaCl) supplemented with one complete protease inhibitor tablet EDTA free (Roche, Basel, Switzerland) per 50 mL of buffer. Cells were lysed by passage through a French press (Emulsiflex C5 homogenizer, Avestin, Ottawa, Canada) and the inclusion bodies isolated by centrifugation at 16,000 rpm for 30 minutes in an SS-34 rotor. The insoluble protein was re-suspended and washed twice with lysis buffer containing 0.1 % Triton X-100 and washed once with lysis buffer alone to remove trace amounts of Triton X-100. The resulting pellet was dissolved in 100 mL of re-suspension buffer (50 mM Tris-HCl pH 7.9, 6 M urea and 500 mM NaCl) and loaded onto a Ni-NTA affinity column. The resin was washed with re-suspension buffer and the fusion protein eluted from the column in 10 mL fractions with re-suspension buffer supplemented with 500 mM imidazole. The fractions were analyzed by SDS-PAGE and those containing the 50 kDa fusion protein were pooled.
Generation of protein α-thioester
Fusion proteins were refolded by step-wise dialysis from a buffer containing, 50 mM Tris-HCl pH 7.6, 100 mM NaCl, 1 mM EDTA and 6 M urea against 50 mM Tris-HCl pH 7.6, 100 mM NaCl and 1 mM EDTA at 4 °C. Thiolysis was initiated by adding sodium 2-mercaptoethane sulfonate (MESNA) to a final concentration of 200 mM and allowed to proceed for 2 days at 25 °C. The thioester-containing cleavage products were purified by preparative scale RP-HPLC on a C 4 column using a gradient of 40-65% buffer B and fractions analyzed by analytical RP-HPLC and ESI-MS. Pure thioester products were pooled, lyophilized and then refolded by step-wise dialysis from a buffer containing, 50
mM Tris-HCl pH 7.6, 100 mM NaCl and 6 M urea against 50 mM Tris-HCl pH 7.6, 100
mM NaCl and 100 mM MESNA at 4 °C. The N-terminal His 6 -tag was proteolytically removed with Factor Xa (1U enzyme/500 mg protein for 6 h at 25 °C). The final thioester products were purified by preparative scale RP-HPLC on C 4 column using a gradient of 40-65% buffer B and analyzed by analytical RP-HPLC and ESI-MS. ~30 mg of pure thioester-containing products were obtained from 1L of E. coli culture ( Supplementary   Fig. 2 ).
Expressed protein ligation
Expressed protein ligation (EPL) was performed at 4 ºC by mixing the appropriate synthetic peptide (3 eq.) and protein α-thioester (1 eq, 1 mM) in ligation buffer (100 mM NaPi pH 7.8, 6M Gmd.Cl 100 mM NaCl) plus 100 mM MESNA and 10 mM TCEP (tris[2-carboxyethyl] phosphine). The reaction was followed by analytical RP-HPLC and ESI-MS. All reactions were >90% complete within 5 days. Semi-synthetic proteins were separated from unreacted precursors on a Ni-NTA affinity column. The resin was washed with buffer (100 mM Tris-HCl pH 7.5, 6M Urea, 100 mM NaCl and 1 mM TCEP), the protein eluted from the column in 8 x 0.5 mL fractions of buffer supplemented with 500 mM imidazole and the fractions analyzed by SDS-PAGE. Finally, the ligated products were purified by semi-preparative scale RP-HPLC on a C 4 column using a gradient of 40-50% solvent B and analyzed by analytical RP-HPLC and ESI-MS (yield 30%, 2 mg).
(Supplemental Fig. 5 & 6 ).
Nuclear magnetic resonance (NMR) spectroscopy
Purified constructs were folded at 4 ºC by stepwise dialysis from denaturing buffer into the buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl and 1 mM TCEP). Fig. 12 ). Data sets were multiplied by a cosine-bell window function and zero-filled to 1,000 points before Fourier transformation using XWINNMR (Bruker Instruments). The corresponding sweep widths were 11.9 ppm, 12.8 ppm, and 33.3 ppm in the 1 H, 13 C, and 15 N dimensions, respectively.
Experimental amide 1 J NC′ coupling constants were obtained by fitting the time evolution of the normalized peak intensities extracted from the series of HNCO-type experiments using the expression I k =e(-4t 1 R 2k )sin 2 (2πJ k t 1 )
where I k are the normalized peak intensities for peak k, R 2 is the transverse relaxation time for peak k, and t 1 is the indirect dimension delay.
